Cargando…

Understanding the variability of pharmaco‐epidemiological studies assessing the risk of appendicitis with mRNA COVID‐19 vaccines

Detalles Bibliográficos
Autores principales:	Jambon‐Barbara, Clement, Bernardeau, Claire, Cracowski, Jean‐Luc, Khouri, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877887/ https://www.ncbi.nlm.nih.gov/pubmed/36351883 http://dx.doi.org/10.1002/pds.5560

Ejemplares similares

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
por: Khouri, Charles, et al.
Publicado: (2021)

Pharmaco-omics data sheds light on therapy-oriented prospects of precision medicine
por: Zheng, Jie, et al.
Publicado: (2021)

Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
por: Khouri, Charles, et al.
Publicado: (2021)

Impact of global warming on Raynaud’s phenomenon: a modelling study
por: Khouri, Charles, et al.
Publicado: (2020)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey
por: Khouri, Charles, et al.
Publicado: (2022)

Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012)

A Tolerizing mRNA Vaccine against Autoimmunity?
por: Furlan, Roberto
Publicado: (2021)

Debunking mRNA Vaccine Misconceptions—An Overview for Medical Professionals
por: Hitti, Frederick L., et al.
Publicado: (2021)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Uveitis following mRNA COVID-19 vaccination: Is it real?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

PHARMACO – THERAPEUTICS OF DASEMANI DRUGS
por: Sircar, N. N.
Publicado: (1984)

ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
por: Crombie, Jennifer L., et al.
Publicado: (2021)

Variable selection: current practice in epidemiological studies
por: Walter, Stefan, et al.
Publicado: (2009)

Cell fate conversion by mRNA
por: Li, Mo, et al.
Publicado: (2011)

From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
por: Bajcar, Jana M, et al.
Publicado: (2010)

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value
por: Zoons, E., et al.
Publicado: (2012)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Overcoming the challenge of long-term storage of mRNA-lipid nanoparticle vaccines
por: Young, Rachel E., et al.
Publicado: (2022)

The epidemiology of sepsis: questioning our understanding of the role of race
por: Valley, Thomas S., et al.
Publicado: (2015)

Facilitated/Pharmaco-invasive Approaches in STEMI
por: Capodanno, Davide, et al.
Publicado: (2012)

Epigenetics and pharmaco-epigenetics in the primary headaches
por: Montagna, Pasquale
Publicado: (2008)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible
por: Sharma, V
Publicado: (2018)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer
por: Kang, Ning, et al.
Publicado: (2023)

Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment
por: Pavlik, Valory N, et al.
Publicado: (2011)

Attending to the lightness of numbers: toward the understanding of critical care epidemiology
por: Okamoto, Valdelis N, et al.
Publicado: (2004)

Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study
por: Chen, Liang-Yu, et al.
Publicado: (2020)

Matrin 3 and HIV Rev Regulation of mRNA
por: Dayton, Andrew I
Publicado: (2011)

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
por: Silvestris, Nicola
Publicado: (2021)

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism
por: Lazaros, George, et al.
Publicado: (2021)

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
por: Bolze, Alexandre, et al.
Publicado: (2022)

mRNA Vaccines for COVID-19: A Simple Explanation
por: Hendaus, Mohamed A., et al.
Publicado: (2021)

Pharmaco-management of inhalation injuries for burn survivors
por: Bartley, Anthony C, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kkqtt678k1vbj2h6k0but9m1ul